Milestone Pharmaceuticals Inc. Gains 166.77%
Thu, Jul 23, 2020 at 05:30 PM
Milestone Pharmaceuticals Inc. (MIST:NASDAQ) rocketted at $8.91, a gain of 166.8%. The stock appeared on our News Catalysts scanner on Thu 23 Jul 20 at 07:52 AM in the 'PRIVATE PLACEMENT' category. From Wed 08 Jul 20, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Tue 09 Jun 20 at $7.14 with a volume of 13M+, and its share price has been moving sideways in recent weeks.
About Milestone Pharmaceuticals Inc. (MIST:NASDAQ)
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
Top 10 Gainers:
- Milestone Pharmaceuticals Inc. (MIST:NASDAQ), 166.77%
- Arbutus Biopharma Corporation (ABUS:NASDAQ), 119.86%
- RigNet, Inc. (RNET:NASDAQ), 48.34%
- Brightcove Inc. (BCOV:NASDAQ), 44.24%
- PolyMet Mining Corp. (PLM:NYSEMKT), 35.93%
- Mogo Inc. (MOGO:NASDAQ), 35%
- Lightbridge Corporation (LTBR:NASDAQ), 29.87%
- Helix Energy Solutions Group, Inc. (HLX:NYSE), 26.96%
- Reed's, Inc. (REED:NASDAQ), 25.96%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 25.07%